Terug
Ook genoteerd als
LTGHY
OTC
Dagbereik
€ 0,68
€ 0,72
52-Weeksbereik
€ 0,68
€ 0,82
Volume
87
50D / 200D Gem.
€ 0,73
/
€ 0,78
Vorige Slotkoers
€ 0,68
Quick Summary
Koershistorie
Financiële Trends
Sectorvergelijking
vs Healthcare sector mediaan (633 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 4,4 | 0,2 |
| P/B | 1,5 | 2,8 |
| ROE % | 3,4 | 3,7 |
| Net Margin % | 15,4 | 3,9 |
| Rev Growth 5Y % | -51,9 | 10,0 |
| D/E | 6,0 | 0,2 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 1,63
€ 1,61 – € 1,68
|
29,47B | 1 |
| FY2027 |
€ 1,51
€ 1,49 – € 1,56
|
27,87B | 1 |
| FY2026 |
€ 1,33
€ 1,32 – € 1,37
|
26,43B | 1 |
No quarterly estimates available
Earnings Surprises
Last 8 quarters
| Quarter | Est. EPS | Actual EPS | Surprise |
|---|---|---|---|
| 2025-05-20 | N/A | -€ 0,08 | — |
| 2024-11-26 | N/A | € 0,16 | — |
| 2024-05-22 | N/A | € 0,13 | — |
| 2024-02-22 | N/A | -€ 0,01 | — |
| 2023-03-31 | N/A | € 0,02 | — |
| 2022-09-30 | N/A | € 0,04 | — |
| 2022-03-31 | N/A | € 0,03 | — |
| 2021-09-30 | € 0,03 | € 0,04 | +24,9% |
Dividend History
6 yr streakYield
0,02%
Payout Ratio
1,35%
Growth (3Y)
103,82%
Growth (5Y)
25,95%
| Ex-Date | Payment Date | Amount | Yield |
|---|---|---|---|
| Dec 19, 2025 | Dec 22, 2025 | € 0,02 | 21,18% |
| Sep 19, 2025 | Sep 22, 2025 | € 0,13 | 25,75% |
| Jun 13, 2025 | Jun 17, 2025 | € 0,01 | 8,37% |
| Jan 10, 2025 | Jan 13, 2025 | € 0,04 | 38,34% |
| Dec 13, 2024 | Dec 17, 2024 | € 0,02 | 34,46% |
| Jun 14, 2024 | Jun 18, 2024 | € 0,01 | 64,63% |
| Apr 03, 2024 | Apr 08, 2024 | € 0,32 | 45,75% |
| Dec 12, 2023 | Dec 18, 2023 | € 0,01 | 2,49% |
| Jun 13, 2023 | Jun 19, 2023 | € 0,01 | 2,33% |
| Dec 07, 2022 | Dec 12, 2022 | € 0,01 | 2,22% |
| Jun 14, 2022 | Jun 20, 2022 | € 0,01 | 1,88% |
| Dec 08, 2021 | Dec 13, 2021 | € 0,02 | 0,95% |
| Dec 11, 2019 | Dec 17, 2019 | € 0,04 | 2,71% |
| Jun 19, 2019 | Jun 24, 2019 | € 0,03 | 3,00% |
| Dec 12, 2018 | Dec 18, 2018 | € 0,04 | 3,27% |
| Jun 20, 2018 | Jun 25, 2018 | € 0,03 | 2,86% |
| Jan 03, 2018 | Jan 08, 2018 | € 0,04 | 3,68% |
| Jun 28, 2017 | Jul 03, 2017 | € 0,03 | 3,08% |
| Dec 13, 2016 | Dec 19, 2016 | € 0,07 | 3,54% |
| Jun 10, 2016 | — | € 0,04 | 3,93% |
Belangrijkste Punten
Revenue declined -51,86% annually over 5 years
Earnings declined -95,40% over the past year
ROE of 3,37% is below average
Net margin of 15,39% shows strong profitability
Debt/Equity of 6,04 — high leverage
Generating 138,29M in free cash flow
Groei
Revenue Growth (5Y)
-51,86%
Revenue (1Y)-94,34%
Earnings (1Y)-95,40%
FCF Growth (3Y)-3,77%
Kwaliteit
Return on Equity
3,37%
ROIC2,06%
Net Margin15,39%
Op. Margin8,77%
Veiligheid
Debt / Equity
6,04
Current Ratio0,07
Interest Coverage6,38
Waardering
P/E Ratio
4,40
Forward P/E0,51
P/B Ratio1,50
EV/EBITDA37,22
Dividend Yield0,02%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -94,34% | Revenue Growth (3Y) | -74,89% |
| Earnings Growth (1Y) | -95,40% | Earnings Growth (3Y) | -8,26% |
| Revenue Growth (5Y) | -51,86% | Earnings Growth (5Y) | -40,34% |
| Profitability | |||
| Revenue (TTM) | 1,44B | Net Income (TTM) | 222,18M |
| ROE | 3,37% | ROA | 15,04% |
| Gross Margin | 23,29% | Operating Margin | 8,77% |
| Net Margin | 15,39% | Free Cash Flow (TTM) | 138,29M |
| ROIC | 2,06% | FCF Growth (3Y) | -3,77% |
| Safety | |||
| Debt / Equity | 6,04 | Current Ratio | 0,07 |
| Interest Coverage | 6,38 | ||
| Dividends | |||
| Dividend Yield | 0,02% | Payout Ratio | 1,35% |
| Dividend Growth (3Y) | 103,82% | Dividend Growth (5Y) | 25,95% |
| Consecutive Div Years | 6 yrs | ||
| Valuation | |||
| P/E Ratio | 4,40 | Forward P/E | 0,51 |
| P/B Ratio | 1,50 | P/S Ratio | 0,68 |
| PEG Ratio | -0,92 | Forward PEG | N/A |
| EV/EBITDA | 37,22 | Fwd EV/EBITDA | 1,39 |
| Forward P/S | 0,04 | Fwd Earnings Yield | 196,08% |
| FCF Yield | 14,13% | ||
| Market Cap | 978,68M | Enterprise Value | 4,71B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 1,44B | 25,52B | 22,89B | 28,21B | 26,89B |
| Net Income | 222,18M | 4,83B | 264,00M | 1,53B | 1,75B |
| EPS (Diluted) | 0,15 | 3,26 | 0,18 | 1,05 | 1,14 |
| Gross Profit | 336,20M | 17,81B | 6,48B | 5,87B | 18,35B |
| Operating Income | 126,56M | 2,90B | 2,44B | 2,76B | 3,01B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1,48B | 24,34B | 45,62B | 42,24B | 40,78B |
| Total Liabilities | 779,01M | 10,83B | 24,33B | 22,38B | 21,61B |
| Shareholders' Equity | 654,18M | 12,54B | 20,21B | 18,75B | 18,07B |
| Total Debt | 3,95B | 4,42B | 13,19B | 13,69B | 12,55B |
| Cash & Equivalents | 219,08M | 2,46B | 846,00M | 2,80B | 2,67B |
| Current Assets | 486,74M | 7,54B | 29,41B | 7,78B | 7,41B |
| Current Liabilities | 7,05B | 5,27B | 11,20B | 7,65B | 7,39B |